1. Home
  2. CPAC vs TBPH Comparison

CPAC vs TBPH Comparison

Compare CPAC & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPAC
  • TBPH
  • Stock Information
  • Founded
  • CPAC 1949
  • TBPH 2013
  • Country
  • CPAC Peru
  • TBPH United States
  • Employees
  • CPAC N/A
  • TBPH N/A
  • Industry
  • CPAC Building Materials
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPAC Industrials
  • TBPH Health Care
  • Exchange
  • CPAC Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • CPAC 485.9M
  • TBPH 464.5M
  • IPO Year
  • CPAC 2012
  • TBPH N/A
  • Fundamental
  • Price
  • CPAC $5.87
  • TBPH $9.16
  • Analyst Decision
  • CPAC Sell
  • TBPH Buy
  • Analyst Count
  • CPAC 1
  • TBPH 3
  • Target Price
  • CPAC $6.00
  • TBPH $11.33
  • AVG Volume (30 Days)
  • CPAC 5.9K
  • TBPH 285.7K
  • Earning Date
  • CPAC 07-21-2025
  • TBPH 05-08-2025
  • Dividend Yield
  • CPAC 8.35%
  • TBPH N/A
  • EPS Growth
  • CPAC 15.59
  • TBPH N/A
  • EPS
  • CPAC 0.13
  • TBPH N/A
  • Revenue
  • CPAC $545,786,617.00
  • TBPH $65,266,000.00
  • Revenue This Year
  • CPAC N/A
  • TBPH $51.09
  • Revenue Next Year
  • CPAC N/A
  • TBPH N/A
  • P/E Ratio
  • CPAC $9.00
  • TBPH N/A
  • Revenue Growth
  • CPAC 2.78
  • TBPH 6.11
  • 52 Week Low
  • CPAC $5.10
  • TBPH $7.44
  • 52 Week High
  • CPAC $6.65
  • TBPH $10.90
  • Technical
  • Relative Strength Index (RSI)
  • CPAC 59.35
  • TBPH 46.92
  • Support Level
  • CPAC $5.65
  • TBPH $9.10
  • Resistance Level
  • CPAC $5.76
  • TBPH $9.45
  • Average True Range (ATR)
  • CPAC 0.13
  • TBPH 0.36
  • MACD
  • CPAC 0.03
  • TBPH -0.02
  • Stochastic Oscillator
  • CPAC 100.00
  • TBPH 65.35

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: